We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

We recently compiled a list of the 7 Blue Chip Stocks with Low PE Ratios. In this article, we are going to take a look at ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...

Clesrovimab (MK-1654), an Investigational RSV Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” third quarter 2024 investor letter ...

Summit Therapeutics has a pipeline candidate that could be more effective than Merck's Keytruda. It's a good start ...

Merck's recent decline is due to reduced profit guidance and FDA decisions, but shares are at a support level. Read why I ...

On Oct. 1 and 2, the American Chemical Society held its 21st annual Pharma Leaders Conference, hosted this year at the Merck & Co. campus in Rahway, New Jersey. Leaders in medicinal chemistry from ...

Expect Merck's revenue to grow at a good clip through 2028. It will likely lose steam once Keytruda's patent expires, but the pharmaceutical giant should recover eventually and deliver solid ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $100.0 to $120.0 for Merck & Co over the last 3 months.

North Carolina Agricultural and Technical State University and Merck (NYSE: MRK), known as MSD outside of the United States ...